CRISPR Therapeutics AG
Earnings Date & Report
Last updated:
CRISPR Therapeutics AG’s last earnings date was on 8 May 2023.
CRISPR Therapeutics AG stock Earnings report, Estimates & History
| 2018-11-07 | -1.5423 | -1.07 |
|---|---|---|
| 2019-02-25 | -1.09048 | -0.92 |
| 2019-04-29 | -0.97901 | -0.93 |
| 2019-07-29 | -1.13595 | -1.01 |
| 2019-10-28 | -6.07392 | 2.4 |
| 2020-02-12 | -0.41555 | 0.51 |
| 2020-04-28 | -1.25913 | -1.15 |
| 2020-07-27 | -1.7862 | -1.3 |
| 2020-10-28 | -1.47061 | -1.32 |
| 2021-02-16 | -1.76745 | -1.5 |
| 2021-04-27 | -1.54835 | -1.51 |
| 2021-07-29 | -6.41637 | 9.44 |
| 2021-11-03 | -1.588 | -1.67 |
| 2022-02-15 | -1.91397 | -1.84 |
| 2022-05-09 | -2.77959 | -2.32 |
| 2022-08-08 | -2.586 | -2.4 |
| 2022-11-01 | -2.29 | -2.24 |
| 2023-02-21 | -0.86475 | -1.41 |
Estimated - a value of Apple’s earnings per share estimated by analysts based on its past and current financial statements.
Reported - a real value of Apple’s earnings per share reported by the company.
CRISPR Therapeutics AG stock earnings history by quarter
| Date | Estimated EPS | Reported EPS | Estimated revenue | Actual revenue | Earnings call | |
|---|---|---|---|---|---|---|
| 8 May 2023 | N/A | -$1.67 | N/A | N/A | N/A | |
| 21 Feb 2023 | Missed | -$0.86 | -$1.41 | 18.45M | 6K | |
| 31 Dec 2022 | N/A | N/A | -$1.41 | N/A | 6K | |
| 1 Nov 2022 | Beat | -$2.29 | -$2.24 | N/A | 94K | |
| 8 Aug 2022 | Beat | -$2.59 | -$2.4 | N/A | 94K | |
| 9 May 2022 | Beat | -$2.78 | -$2.32 | 143.13K | 158K | |
| 15 Feb 2022 | Beat | -$1.91 | -$1.84 | 2.14M | 178K | |
| 3 Nov 2021 | Missed | -$1.59 | -$1.67 | 833.75K | 12.89M | |
| 29 Jul 2021 | Beat | -$6.42 | $9.44 | 845.93M | 824K | |
| 27 Apr 2021 | Beat | -$1.55 | -$1.51 | 1.21M | 900.70M | |
| 16 Feb 2021 | Beat | -$1.77 | -$1.5 | 2.5M | 539K | |
| 28 Oct 2020 | Beat | -$1.47 | -$1.32 | 132.30K | 370K | |
| 27 Jul 2020 | Beat | -$1.79 | -$1.3 | 32.15K | 148K | |
| 28 Apr 2020 | Beat | -$1.26 | -$1.15 | 143.34K | 44K | |
| 12 Feb 2020 | Beat | -$0.42 | $0.51 | 95.13M | 157K | |
| 28 Oct 2019 | Beat | -$6.07 | $2.4 | 83.88M | 77.01M | |
| 29 Jul 2019 | Beat | -$1.14 | -$1.01 | 283.36K | 211.92M | |
| 29 Apr 2019 | Beat | -$0.98 | -$0.93 | 310.36K | 318K | |
| 25 Feb 2019 | Beat | -$1.09 | -$0.92 | 97.5K | 328K | |
| 7 Nov 2018 | Beat | -$1.54 | -$1.07 | 389.36K | 115K | |
CRISPR Therapeutics AG Earnings report FAQs
When is CRISPR Therapeutics AG's next Earnings date?
The company has not set the next earnings date yet. The latest CRISPR Therapeutics AG's earnings date was on 8 Aug 2022.
What are earnings?
Earnings are the net income of a company after all taxes and expenses have been deducted. They are the main figure for determining the price of a company's shares.
What does EPS stand for?
EPS stands for earnings per share, which is the basic measure of a company's earnings. It indicates how much money each share earned for the company.
How to calculate earnings per share?
Earnings per share (EPS) can be calculated by dividing a company's net income by the number of common shares outstanding. If the company pays preferred dividends, they are first subtracted from the company’s net income.
Formula:
What is earnings per share estimate?
Earnings estimate is analysts’ prediction of a company’s earnings value in the next quarter or fiscal year based on past and current financial statements of a company. It is an important indicator for both current and future investors.